Page 23 - Platform Technology News Today

People have questioned the analysis ...by Dr. Ladapo that found an 84% increase in cardiac-related deaths in boys...

/PRNewswire/ -- Pain is a normal part of life. The ability to feel pain and know when something hurts is an important factor that keeps humanity safe. But...

/PRNewswire/ -- Sinoveda is bringing the health-science world together by unifying the best parts of Eastern and Western medicine. The brand specializes in...

Patients with rare forms of melanoma that affect the eye and we have also seen with his sister virus from this, really the next version of this virus beginnings activities against a rare, assertive, soft tissue tumour and we have seen responses there which we really did not anticipate. these are very interesting and intriguing data. ., ., data. how long could it take for more — data. how long could it take for more trials _ data. how long could it take for more trials and - data. how long coul...

BUFFALO, N.Y., Sept. 20, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the...

Here they are... the winners at the 2022 Schroders UK Platform Awards.

$20 Million Cash Gain from Partial IP Asset Sale and Strong Financial Growth with Projected Acceleration: CURE Pharmaceutical: (Stock Symbol: CURR)

Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class therapeutic index, today announces that the Company was awarded ‘Best ADC Platform Technology’ at the World ADC Conference 2022. This ...

The editors of JAMA recognize the challenges, concerns, and frustration about the shortage of personal protective equipment (PPE) that is affecting the care of

/PRNewswire/ -- Synaffix B.V., a biotechnology company focused on commercializing its clinical-stage platform technology for the development of antibody-drug...